This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, S.
Right arrow Articles by Klausner, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, S.
Right arrow Articles by Klausner, R. D.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, February 1999, p. 1486-1497, Vol. 19, No. 2
0270-7306/99/$00.00+0

Transcription-Dependent Nuclear-Cytoplasmic Trafficking Is Required for the Function of the von Hippel-Lindau Tumor Suppressor Protein

Stephen Lee,1,* Markus Neumann,2,dagger Robert Stearman,1 Roland Stauber,2 Arnim Pause,1 George N. Pavlakis,2 and Richard D. Klausner1,3

Cell Biology and Metabolism Branch, National Institute of Child Health and Human Development,1 and Office of the Director, National Cancer Institute,3 National Institutes of Health, Bethesda, Maryland 20892, and NCI-Frederick Cancer Research Development Center, ABL-Basic Research Program, Frederick, Maryland 217022

Received 12 August 1998/Returned for modification 4 September 1998/Accepted 16 November 1998

Mutation of the von Hippel-Lindau tumor suppressor gene (vhl) causes the von Hippel-Lindau cancer syndrome as well as sporadic renal clear cell carcinoma. To pursue our study of the intracellular localization of VHL protein in relation to its function, we fused VHL to the green fluorescent protein (GFP) to produce the VHL-GFP fusion protein. Like VHL, VHL-GFP binds to elongins B and C and Cullin-2 and regulates target gene product levels, including levels of vascular endothelial growth factor and glucose transporter 1. VHL-GFP localizes predominantly to the cytoplasm, with some detectable nuclear signal. Inhibition of transcription by actinomycin D or 5,6-dichlorobenzimidazole riboside (DRB) causes VHL to be redistributed to the nucleus. A cellular fusion assay was used to demonstrate that inhibition of transcription induces a decrease in the nuclear export rate of VHL. The dependence of transcription for trafficking is lost with a deletion of exon 2, a region with a mutation causing a splice defect in the VHL gene in sporadic renal clear cell carcinoma. Addition of a strong nuclear export signal (NES) derived from the Rev protein results in complete nuclear exclusion and abrogates the redistribution of VHL-GFP-NES into the nucleus upon inhibition of transcription. Leptomycin B, which inhibits NES-mediated nuclear export, reverts the distribution of VHL-GFP-NES to that of VHL-GFP and restores sensitivity to actinomycin D and DRB. Uncoupling of VHL-GFP trafficking to transcription either by an exon 2 deletion or fusion to NES abolishes VHL function. We suggest that VHL function requires not only nuclear or cytoplasmic localization, but also exon 2-mediated transcription-dependent trafficking between these two cellular compartments.

* Corresponding author. Present address: Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, 451 Smyth Rd., Ottawa, Ontario, Canada K1H 8M5. Phone: (613) 562-5800, ext. 8385. Fax: (613) 562-5434. E-mail: slee{at}uottawa.ca.

dagger Present address: GSF-National Research Center for Environment and Health, Institute for Molecular Virology, 85758 Neuherberg, Germany.

Molecular and Cellular Biology, February 1999, p. 1486-1497, Vol. 19, No. 2
0270-7306/99/$00.00+0


This article has been cited by other articles:

  • Khacho, M., Mekhail, K., Pilon-Larose, K., Pause, A., Cote, J., Lee, S. (2008). eEF1A Is a Novel Component of the Mammalian Nuclear Protein Export Machinery. Mol. Biol. Cell 19: 5296-5308 [Abstract] [Full Text]  
  • Khacho, M., Mekhail, K., Pilon-Larose, K., Payette, J., Lee, S. (2008). Cancer-Causing Mutations in a Novel Transcription-Dependent Nuclear Export Motif of VHL Abrogate Oxygen-Dependent Degradation of Hypoxia-Inducible Factor. Mol. Cell. Biol. 28: 302-314 [Abstract] [Full Text]  
  • Mylonis, I., Chachami, G., Samiotaki, M., Panayotou, G., Paraskeva, E., Kalousi, A., Georgatsou, E., Bonanou, S., Simos, G. (2006). Identification of MAPK Phosphorylation Sites and Their Role in the Localization and Activity of Hypoxia-inducible Factor-1{alpha}. J. Biol. Chem. 281: 33095-33106 [Abstract] [Full Text]  
  • O'Hare, M. J., Kushwaha, N., Zhang, Y., Aleyasin, H., Callaghan, S. M., Slack, R. S., Albert, P. R., Vincent, I., Park, D. S. (2005). Differential Roles of Nuclear and Cytoplasmic Cyclin-Dependent Kinase 5 in Apoptotic and Excitotoxic Neuronal Death. J. Neurosci. 25: 8954-8966 [Abstract] [Full Text]  
  • Mekhail, K., Khacho, M., Carrigan, A., Hache, R. R.J., Gunaratnam, L., Lee, S. (2005). Regulation of ubiquitin ligase dynamics by the nucleolus. JCB 170: 733-744 [Abstract] [Full Text]  
  • KAELIN, W.G. JR. (2005). The von Hippel-Lindau Tumor Suppressor Protein: Roles in Cancer and Oxygen Sensing. Cold Spring Harb Symp Quant Biol 70: 159-166 [Abstract]  
  • Kim, W. Y., Kaelin, W. G. (2004). Role of VHL Gene Mutation in Human Cancer. JCO 22: 4991-5004 [Abstract] [Full Text]  
  • Kaelin, W. G. Jr. (2004). The Von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer. Clin. Cancer Res. 10: 6290S-6295S [Abstract] [Full Text]  
  • Rafalska, I., Zhang, Z., Benderska, N., Wolff, H., Hartmann, A. M., Brack-Werner, R., Stamm, S. (2004). The intranuclear localization and function of YT521-B is regulated by tyrosine phosphorylation. Hum Mol Genet 13: 1535-1549 [Abstract] [Full Text]  
  • Champagne, C., Landry, M.-C., Gingras, M.-C., Lavoie, J. N. (2004). Activation of Adenovirus Type 2 Early Region 4 ORF4 Cytoplasmic Death Function by Direct Binding to Src Kinase Domain. J. Biol. Chem. 279: 25905-25915 [Abstract] [Full Text]  
  • Kaelin, W. G. Jr. (2003). The von Hippel-Lindau Gene, Kidney Cancer, and Oxygen Sensing. J. Am. Soc. Nephrol. 14: 2703-2711 [Abstract] [Full Text]  
  • Walther, R. F., Lamprecht, C., Ridsdale, A., Groulx, I., Lee, S., Lefebvre, Y. A., Hache, R. J. G. (2003). Nuclear Export of the Glucocorticoid Receptor Is Accelerated by Cell Fusion-dependent Release of Calreticulin. J. Biol. Chem. 278: 37858-37864 [Abstract] [Full Text]  
  • Schraml, P., Hergovitz, A., Hatz, F., Amin, M. B., Lim, S. D., Krek, W., Mihatsch, M. J., Moch, H. (2003). Relevance of Nuclear and Cytoplasmic von Hippel Lindau Protein Expression for Renal Carcinoma Progression. Am. J. Pathol. 163: 1013-1020 [Abstract] [Full Text]  
  • Robert, A., Miron, M.-J., Champagne, C., Gingras, M.-C., Branton, P. E., Lavoie, J. N. (2002). Distinct cell death pathways triggered by the adenovirus early region 4 ORF 4 protein. JCB 158: 519-528 [Abstract] [Full Text]  
  • Groulx, I., Lee, S. (2002). Oxygen-Dependent Ubiquitination and Degradation of Hypoxia-Inducible Factor Requires Nuclear-Cytoplasmic Trafficking of the von Hippel-Lindau Tumor Suppressor Protein. Mol. Cell. Biol. 22: 5319-5336 [Abstract] [Full Text]  
  • Hansen, W. J., Ohh, M., Moslehi, J., Kondo, K., Kaelin, W. G., Welch, W. J. (2002). Diverse Effects of Mutations in Exon II of the von Hippel-Lindau (VHL) Tumor Suppressor Gene on the Interaction of pVHL with the Cytosolic Chaperonin and pVHL-Dependent Ubiquitin Ligase Activity. Mol. Cell. Biol. 22: 1947-1960 [Abstract] [Full Text]  
  • Pioli, P. A., Rigby, W. F. C. (2001). The Von Hippel-Lindau Protein Interacts with Heteronuclear Ribonucleoprotein A2 and Regulates Its Expression. J. Biol. Chem. 276: 40346-40352 [Abstract] [Full Text]  
  • Yang, H., Kaelin, W. G. Jr. (2001). Molecular Pathogenesis of the Von Hippel-Lindau Hereditary Cancer Syndrome: Implications for Oxygen Sensing. Cell Growth Differ. 12: 447-455 [Full Text]  
  • Yu, F., White, S. B., Zhao, Q., Lee, F. S. (2001). Dynamic, Site-specific Interaction of Hypoxia-inducible Factor-1{{alpha}} with the von Hippel-Lindau Tumor Suppressor Protein. Cancer Res. 61: 4136-4142 [Abstract] [Full Text]  
  • Neumann, M, Afonina, E, Ceccherini-Silberstein, F, Schlicht, S, Erfle, V, Pavlakis, G., Brack-Werner, R (2001). Nucleocytoplasmic transport in human astrocytes: decreased nuclear uptake of the HIV Rev shuttle protein. J. Cell Sci. 114: 1717-1729 [Abstract]  
  • Mendell, J. T., Medghalchi, S. M., Lake, R. G., Noensie, E. N., Dietz, H. C. (2000). Novel Upf2p Orthologues Suggest a Functional Link between Translation Initiation and Nonsense Surveillance Complexes. Mol. Cell. Biol. 20: 8944-8957 [Abstract] [Full Text]  
  • Lavoie, J. N., Champagne, C., Gingras, M.-C., Robert, A. (2000). Adenovirus E4 Open Reading Frame 4-Induced Apoptosis Involves Dysregulation of Src Family Kinases. JCB 150: 1037-1056 [Abstract] [Full Text]  
  • Shiao, Y.-H., Resau, J. H., Nagashima, K., Anderson, L. M., Ramakrishna, G. (2000). The von Hippel-Lindau Tumor Suppressor Targets to Mitochondria. Cancer Res. 60: 2816-2819 [Abstract] [Full Text]  
  • Harris, A. L. (2000). von Hippel-Lindau Syndrome: Target for Anti-Vascular Endothelial Growth Factor (VEGF) Receptor Therapy. The Oncologist 5: 32-36 [Abstract] [Full Text]  
  • Groulx, I., Bonicalzi, M.-E., Lee, S. (2000). Ran-mediated Nuclear Export of the von Hippel-Lindau Tumor Suppressor Protein Occurs Independently of Its Assembly with Cullin-2. J. Biol. Chem. 275: 8991-9000 [Abstract] [Full Text]  
  • Ludwig, E., Silberstein, F. C., van Empel, J., Erfle, V., Neumann, M., Brack-Werner, R. (1999). Diminished Rev-Mediated Stimulation of Human Immunodeficiency Virus Type 1 Protein Synthesis Is a Hallmark of Human Astrocytes. J. Virol. 73: 8279-8289 [Abstract] [Full Text]  
  • Marx, S. J. (1999). CLINICAL REVIEW 109: Contrasting Paradigms for Hereditary Hyperfunction of Endocrine Cells. J. Clin. Endocrinol. Metab. 84: 3001-3009 [Full Text]  
  • Lisztwan, J., Imbert, G., Wirbelauer, C., Gstaiger, M., Krek, W. (1999). The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev. 13: 1822-1833 [Abstract] [Full Text]  
  • Bonicalzi, M.-E., Groulx, I., de Paulsen, N., Lee, S. (2001). Role of Exon 2-encoded beta -Domain of the von Hippel-Lindau Tumor Suppressor Protein. J. Biol. Chem. 276: 1407-1416 [Abstract] [Full Text]  
  • Devarajan, P., De Leon, M., Talasazan, F., Schoenfeld, A. R., Davidowitz, E. J., Burk, R. D. (2001). The von Hippel-Lindau Gene Product Inhibits Renal Cell Apoptosis via Bcl-2-dependent Pathways. J. Biol. Chem. 276: 40599-40605 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»